Context Therapeutics Inc. (CNTX): Ready for an explosive trading day – Invest Chronicle

Context Therapeutics Inc. (CNTX): Ready for an explosive trading day

Let’s start up with the current stock price of Context Therapeutics Inc. (CNTX), which is $2.23 to be very precise. The Stock rose vividly during the last session to $2.506 after opening rate of $2.50 while the lowest price it went was recorded $2.365 before closing at $2.39.Recently in News on January 5, 2022, Context Therapeutics® Strengthens Research & Development Team. Company names Christopher Beck as SVP, Operations and Mark Fletcher, Ph.D., as VP, R&D. You can read further details here

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Context Therapeutics Inc. shares are logging -79.50% during the 52-week period from high price, and -3.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.30 and $10.87.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 618515 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Context Therapeutics Inc. (CNTX) recorded performance in the market was -10.15%. At the time of this writing, the total market value of the company is set at 26.46M, as it employees total of 2 workers.

Context Therapeutics Inc. (CNTX) in the eye of market guru’s

During the last month, 0 analysts gave the Context Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

>> 7 Top Picks for the Post-Pandemic Economy << 

Context Therapeutics Inc. (CNTX): Stocks Technical analysis and Trends

Raw Stochastic average of Context Therapeutics Inc. in the period of last 50 days is set at 0.23%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.55%. In the last 20 days, the company’s Stochastic %K was 9.14% and its Stochastic %D was recorded 11.50%.

If we look into the earlier routines of Context Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -10.15%. The shares increased approximately by -6.27% in the 7-day charts and went up by -35.23% in the period of the last 30 days.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts